H1 Pipeline for Herpes Zoster (Shingles) and Market Key Clinical Trial Data and Major Players Analyzed in 2017 Report
May 8, 2017
Herpes Zoster (Shingles) Market Analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
May 8, 2017 /MarketersMedia/ —
Herpes Zoster Market (Shingles) - Pipeline Review, H1 2017 is new market research report added to ReportsnReports.com online store. Herpes Zoster market provides an overview of the Herpes Zoster (Shingles) (Infectious Disease) pipeline landscape.
Browse the 22 Tables and 10 Figures, 13 Company Profiles, Spread across 63 Pages Report Available at http://www.reportsnreports.com/contacts/discount.aspx?name=983988 .
Herpes Zoster market report provides comprehensive information on the therapeutics under development for Herpes Zoster (Shingles) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Herpes Zoster market companies are Astellas Pharma Inc, Beijing Minhai Biotechnology Co Ltd, ContraVir Pharmaceuticals Inc, Epiphany Biosciences Inc, Foamix Pharmaceuticals Ltd, GeneOne Life Science Inc, GlaxoSmithKline Plc, Merck & Co Inc, NAL Pharmaceuticals Ltd, NanoViricides Inc, SK Chemicals Co Ltd, TSRL Inc, XBiotech Inc.
Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=983988
Herpes Zoster (Shingles) - Acyclovir Drug Profiles: Product Description, Mechanism Of Action, R&D Progress. The pipeline guide reviews key companies involved in Herpes Zoster (Shingles) (Infectious Disease) therapeutics and enlists all their major and minor projects.
The Herpes Zoster (Shingles) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Zoster (Shingles) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Unknown stages are 2, 3, 1, 1, 6 and 1 respectively.
Herpes Zoster Market (Shingles) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope : - The pipeline guide provides a snapshot of the global therapeutic landscape of Herpes Zoster (Shingles) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Herpes Zoster (Shingles) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Herpes Zoster (Shingles) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Herpes Zoster (Shingles) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Herpes Zoster (Shingles) (Infectious Disease)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Herpes Zoster (Shingles) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Herpes Zoster (Shingles) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact Info:
Name: Ritesh Tiwari
Email: [email protected]
Organization: ReportsnReports.com
For more information, please visit http://www.reportsnreports.com/reports/983988-herpes-zoster-shingles-pipeline-review-h1-2017.html
Source: MarketersMedia
Release ID: 195362
More News
SI is the future of AI – just not in the way Trump thinks
With US President Donald Trump recently pushing the use of “superintelligence” (SI) instead of artificial intelligence (AI) in national discourse, the acronym has gained unprecedented attention. It is the right acronym but the wrong meaning. In my opinion, SI should stand for “self-intelligence”. It probably explains why academics, critics and even major AI companies are calling for a temporary pause in AI development. They must have realised the technology’s current trajectory is headed down...
200 nations at Cop17 commit to biodiversity goals amid missed opportunities
Nearly 200 nations have struck hard-fought agreements at a UN biodiversity summit, but the outcome was accompanied by disappointment over missed opportunities to address humanity’s destructive toll on nature. Delegates cheered on Friday as crucial texts were approved in overtime but the celebrations were tempered by acrimonious debates and regret over limited progress on some of the most contentious issues. The Cop17 summit in Armenia sought to revive a landmark commitment to halt and reverse...
Apple Intelligence to roll out on iPhones in China in December with Alibaba backing
Apple’s long-awaited artificial intelligence features will be officially launched in China in December, ending two years of regulatory uncertainty as the US tech giant seeks to bring advanced technologies to its second-largest market with the help of Alibaba Group Holding. The first batch of Apple Intelligence services will roll out to Chinese iPhone users alongside the iOS 27.3 update in December, following an open beta test with developers starting November 4, the US company said in a...
Both Japan and China can help Bangladesh reach its full potential
In the Land of the Rising Sun, Bangladesh looks forward to a new dawn. The hope that comes with Prime Minister Tarique Rahman’s visit to Japan goes beyond the deals signed or the financial support expected. It shows a country that has emerged from authoritarian rule and wants to turn its new political voice into bigger economic chances and freedom of choice. For a government chosen by the people, foreign policy must answer one question: how does it make life better for the people who gave it...
Can battery swapping and energy storage power CATL’s next phase of growth?
Contemporary Amperex Technology Ltd (CATL) has doubled down on new businesses including battery swapping and energy storage as the world’s largest battery maker seeks new growth drivers amid intensifying price wars and mounting pressure on profitability. But the new path is far from straightforward. Established players like Nio have already built a strong presence in battery swapping, while BYD has reinforced its position in energy-storage systems. Lucas Zhang Liutong, director of Hong...
Liu Yandong, Rare Woman Among China’s Political Elite, Dies at 80
The former vice premier was one of just six women to have served on the Chinese Communist Party’s elite Politburo, though she was excluded from the top ranks of power.
China joins global race to reawaken brain-injury patients through ultrasound therapy
After spending three months in a coma following a brain haemorrhage, a patient in China has regained the ability to speak, eat and walk with support – part of an early clinical trial using targeted sound waves to help “wake up” severely damaged brains, according to state media. The technology, developed by a coalition including the Chinese Academy of Sciences’ Shenzhen Institutes of Advanced Technology, used focused ultrasound waves to stimulate regions deep within the brain without requiring...
Malaysia’s Melaka poll begins as 79 cleared in test for Anwar’s coalition
Malaysia’s Melaka state began its election campaign on Saturday after 79 candidates were cleared to contest a poll testing whether Prime Minister Anwar Ibrahim’s governing partners can turn an opportunistic alliance with his Islamist opponents into a platform for national power. The coastal state south of Kuala Lumpur heads to the polls on November 14, handing the United Malays National Organisation (Umno) and the Pan-Malaysian Islamic Party (PAS) another opening to deepen cooperation after...
US, South Korea and Japan reaffirm North Korea denuclearisation stance
The United States, South Korea and Japan reaffirmed their commitment to the “complete denuclearisation” of North Korea on Saturday, as Pyongyang continues to reject disarmament ahead of possible talks with Washington. Speculation is mounting over a potential meeting between US President Donald Trump and North Korean leader Kim Jong-un at next month’s Apec summit in China, with Trump making repeated overtures to Pyongyang for nuclear talks. US Secretary of State Marco Rubio, South Korean Foreign...
How One Country Became the Unlikely Crossroads of the Global A.I. Boom
In Malaysia, U.S. and Chinese tech giants are pouring billions into vast data centers, straining local resources and testing the limits of Washington’s restrictions on advanced chips.
As AI cyber risks grow, Chinese chip expert urges shared ethics standards with US rivals
The co-founder of Chinese chip giant Cambricon Technologies urged the introduction of universal ethical requirements for leading Chinese and American artificial intelligence models on Friday to mitigate growing risks to society. Chen Yunji’s remarks at an event in Shanghai come as the rapid advance of AI systems globally has resulted in a string of high-profile cyberattacks that have threatened critical infrastructure and breached government servers. Predicting that AI advances would develop...
Will Digging Up Vietnam’s War Dead Heal Old Wounds or Reopen Them?
A 500-day campaign to find and identify fallen soldiers has unearthed hundreds of bodies, but not everyone gets a chance at closure.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.